Published in Clinical Trials Week, September 5th, 2005
"Levocetirizine is a potent and highly selective H1-antihistamine with a proven efficacy in adults," pediatricians in France explained.
"Studies evaluating newer antihistamines in children are few," noted J. de Blic and colleagues working at the H˘pital des Enfants Malades in Paris, who evaluated "the efficacy of levocetirizine 5 mg once-daily" in reducing SAR symptoms, "as measured by Total Four Symptom Score (T4SS=sum of sneezing, rhinorrhea, nasal and ocular pruritus), over the first 2 wk of treatment."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.